Stocks
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | -3.34 | -21.7 | 10.8 | -3.23 | 0.61 | -0.31 | |
| Changes by years, y/y, % | -46% | +550% | -150% | -130% | -119% | |||
Arcturus Therapeutics Holdings. EV/EBITDA
Arcturus Therapeutics Holdings. EV/EBITDA, changes, %
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -3.07 | -5.23 | 0.66 | -0.47 | -0.27 | -0.31 | |
| Changes by years, y/y, % | -185% | -17% | -123% | -70% | -91% | |||
| Changes by quarters, q/q, % | +95% | +71% | -113% | -171% | -43% | |||
